Episode 4: Only the Beginning for Advanced Migraine Treatment

November 14, 2019
Matt Hoffman
Matt Hoffman

Matt Hoffman, Senior Editor for NeurologyLive, has covered medical news for MJH Life Sciences, NeurologyLive’s parent company, since 2017. He hosts the NeurologyLive Mind Moments podcast, as well as Second Opinion on Medical World News. Follow him on Twitter @byMattHoffman or email him at mhoffman@neurologylive.com

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Amaal Starling, MD.

Amaal Starling, MD

Episode 4 of the NeurologyLive Mind Moments podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.

Episode 4, "Only the Beginning: Advancing Migraine Treatment" features an interview with Amaal Starling, MD, assistant professor of neurology at Mayo Clinic Scottsdale, who shared her experiences with a number of new migraine drugs and devices and the impact that more options will have on clinical practice. Starling also discussed what still needs to be done in the migraine space in light of recent advancements.

Click here to subscribe to the Mind Moments podcast. Thanks for listening!